Schizophrenia Research
Volume 116, Issue 1 , Pages 9-15 , January 2010

Social disability in schizophrenic, schizoaffective and affective disorders 15years after first admission

  • Ronald Bottlender

      Affiliations

    • East London NHS Foundation Trust, Department of Psychiatry, Newham Centre for Mental Health, Glen Road, Cherry Tree Way, London E13 8SP, United Kingdom
    • Department of Psychiatry, Ludwig Maximilians University, Nussbaumstrasse 7, 80336 Munich, Germany
    • Corresponding Author InformationCorresponding author. East London NHS Foundation Trust, Department of Psychiatry, Newham Centre for Mental Health, Glen Road, Cherry Tree Way, London E13 8SP, United Kingdom. Tel.: +44 20 7540 5076, +44 7814 691914 (mobile); fax: +44 20 7540 6772.
    • ,
  • Anton Strauß

      Affiliations

    • Department of Psychiatry, Ludwig Maximilians University, Nussbaumstrasse 7, 80336 Munich, Germany
    • ,
  • Hans-Jürgen Möller

      Affiliations

    • Department of Psychiatry, Ludwig Maximilians University, Nussbaumstrasse 7, 80336 Munich, Germany

Received 2 June 2009 ,Revised 9 September 2009 ,Accepted 11 October 2009.

References 

  1. Angst, J., Stassen, H.H., Woggon, B. 1989. Effect of neuroleptics on positive and negative symptoms and the deficit state. Psychopharmacology (Berlin) 99, 41–46.
  2. Arbeitsgemeinschaft für Methodik und Diagnostik in der Psychiatrie (AMDP): Manual Zur Dokumentation Psychiatrischer Befunde. (Association for Methodology and Documentation in Psychiatry (AMDP): Manual for the documentation of psychiatric assessments). 2000. Göttingen; Bern; Toronto; Seattle : Hogrefe, Verl. für Psychologie.
  3. Bearden CE, Hoffman KM, Cannon TD. The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review. Bipolar Disord. 2001;3(3):106–150
  4. Bobon D, Woggon B. The AMDP system in clinical psychopharmacology. Br. J. Psychiatry. 1986;148:467–468
  5. Bottlender R, Sato T, Groll C, Jäger M, Kunze I, Möller HJ. Negative symptoms in depressed and schizophrenic patients: how do they differ?. J. Clin. Psychiatry. 2003;64(8):954–958
  6. Burns T, Patrick D. Social functioning as an outcome measure in schizophrenia studies. Acta. Psychiatr. Scand. 2007;116(6):403–418
  7. Faehndrich, E., Helmchen, H., Hippius, H., 1983. The history of the AMDP System. Mod. Probl. Pharmacopsychiatry 20, 10–18.
  8. Frith CD. The cognitive abnormalities underlying the symptomatology and the disability of patients with schizophrenia. Int. Clin. Psychopharmacol. 1995;10(Suppl 3):87–98
  9. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am. J. Psychiatry. 1996;153(3):321–330
  10. Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”?. Schizophr. Bull. 2000;26(1):119–136
  11. Jung, E., Krumm, B., Biehl, H., Maurer, K., Bauer-Schubart, C., 1989. Mannheimer Skala zur Einschätzung sozialer Behinhinderung, DAS-M. (Mannheim scale for the assessment of social disability.) Beltz Test GmbH, Weinheim; 1989.
  12. Kuny, S., von Luckner, N., Baenninger, R., Bauer, P., Eichenberger, G., Woggon, B. 1983. Interrater reliability of AMDP and AMP symptoms. In: Bobon, D., Baumann, U., Angst, J., Helmchen, H., Hippius, H. (Eds.), AMDP-System in Pharmacopsychiatry. Karger, Basel, pp. 143–160.
  13. Kurzban R, Leary MR. Evolutionary origins of stigmatization: the functions of social exclusion. Psychol. Bull. 2001;127(2):187–208
  14. Leucht S, Lasser R. The concepts of remission and recovery in schizophrenia. Pharmacopsychiatry. 2006;39(5):161–170
  15. Marneros A, Deister A, Rohde A. Psychopathological and social status of patients with affective, schizophrenic and schizoaffective disorders after long-term course. Acta Psychiatr. Scand. 1990;82(5):352–358
  16. Martinez-Aran A, Penades R, Vieta E, Colom F, Reinares M, Benabarre A, et al. Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome. Psychother. Psychosom. 2002;71(1):39–46
  17. Martinez-Aran A, Vieta E, Colom F, Reinares M, Benabarre A, Torrent C, et al. Neuropsychological performance in depressed and euthymic bipolar patients. Neuropsychobiology. 2002;46(Suppl 1):16–21
  18. Möller HJ, Von Zerssen D. In: Der Verlauf schizophrener Psychosen unter den gegenwärtigen Behandlungsbedingungen. (The course of schizoophrenic psychoses under the current care conditions.). Berlin: Springer-Verlag; 1986;
  19. Möller HJ, Schmid-Bode W, Cording-Tommel C, Wittchen HU, Zaudig M, von Zerssen D. Psychopathological and social outcome in schizophrenia versus affective/schizoaffective psychoses and prediction of poor outcome in schizophrenia. Results from a 5–8year follow-up. Acta Psychiatr. Scand. 1988;77(4):379–389
  20. Möller H-J, Bottlender R, Gross A, Hoff P, Wittmann J, Wegner U, et al. The Kraepelinian dichotomy: preliminary results of a 15-year follow-up study on functional psychoses: focus on negative symptoms. Schizophr Res. 2002;56(1–2):87–94
  21. Mueser KT, Bellack AS, Morrison RL, Wixted JT. Social competence in schizophrenia: premorbid adjustment, social skill, and domains of functioning. J. Psychiatr. Res. 1990;24(1):51–63
  22. In:  Murray CJL,  Lopez AD editor. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Disease, Injuries, and Risk Factors in 1990 and Projected to 2020. Harvard University Press; 1996;
  23. Pietzcker A, Gebhardt R, Strauss A, Stockel M, Langer C, Freudenthal K. The syndrome scales in the AMDP-system. Mod. Probl. Pharmacopsychiatry. 1983;20:88–99
  24. Renfordt, E., Busch, H., von Cranach, M., Gulbinat, W., Tegeler, M., 1983. Particular aspects of the interrater reliability of the AMDP psychopathology scale. In: Bobon, D., Baumann, U., Angst, J., Helmchen, H., Hippius, H. (Eds.), AMDP-System in Pharmacopsychiatry. Karger, Basel, pp. 125–142.
  25. Rymaszewska J, Jarosz-Nowak J, Kiejna A, Kallert T, Schützwohl M, Priebe S, et al. Social disability in different mental disorders. Eur. Psychiatry. 2007;22(3):160–166
  26. Sayce L. Stigma, discrimination and social exclusion: what's in a word?. Journal of Mental Health. 1998;7(4):331-343(13)
  27. Wiersma D, Wanderling J, Dragomirecka E, Ganev K, Harrison G, An Der Heiden W, et al. Social disability in schizophrenia: its development and prediction over 15years in incidence cohorts in six European centres. Psychol. Med. 2000;30(5):1155–1167
  28. Woonings FM, Appelo MT, Kluiter H, Slooff CJ, van den Bosch RJ. Learning (potential) and social functioning in schizophrenia. Schizophr. Res. 2003;59(2–3):287–296
  29. Zarate CA, Tohen M, Land M, Cavanagh S. Functional impairment and cognition in bipolar disorder. Psychiatr. Q. 2000;71(4):309–329

PII: S0920-9964(09)00495-2

doi: 10.1016/j.schres.2009.10.008

Schizophrenia Research
Volume 116, Issue 1 , Pages 9-15 , January 2010

Article Tools

* Image Usage & Resolution